Interleukin-3 (Immunex)
白介素-3
Report date: 2022/02/08 17:58:38
Base Information
Drug NameInterleukin-3 (Immunex)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksWikipedia